October 01, 2014 9:46 AM ET

Pharmaceuticals

Company Overview of Kanisa Pharmaceuticals, Inc.

Executive Profile

Alan F. List M.D.

Member of Scientific Advisory Board, CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Alan F. List, M.D., serves as the President and Chief Executive Officer of Moffitt Cancer Center. Dr. List serves as the Chief of the Hematologic Division at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, and Professor of Medicine and Oncology of the University of South Florida College of Medicine. He is a senior member in the Department of Malignant Hematology and the Experimental Therapeutics Program. Dr. List serves as an editor of Leukemia Research ...

Corporate Headquarters

12264 El Camino Real
San Diego, California 92130

United States

Phone: 858-436-1800
Fax: 858-436-1801

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
The University of Pennsylvania
MS
Bucknell University
BS
Bucknell University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Michael M. Goldberg M.D., M.B.A.Interim Chief Executive Officer and Director
Navidea Biopharmaceuticals, Inc
--
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kanisa Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.